Fluids in the treatment of diabetic ketoacidosis in children: A systematic review

Abstract

Aim: To determine the comparative effectiveness of fluid schemes for children with diabetic ketoacidosis (DKA).

Methods: We conducted a systematic review with an attempt to conduct network meta-analysis (NMA). We searched MEDLINE, EMBASE, CENTRAL, Epistemonikos, Virtual Health Library, and gray literature from inception to July 31, 2022. We included randomized controlled trials (RCTs) in children with DKA evaluating any intravenous fluid schemes. We planned to conduct NMA to compare all fluid schemes if heterogeneity was deemed acceptable.

Results: Twelve RCTs were included. Studies were heterogeneous in the population (patients and DKA episodes), interventions with different fluids (saline, Ringer's lactate (RL), and polyelectrolyte solution-PlasmaLyte^®), tonicity, volume, and administration systems. We identified 47 outcomes that measured clinical manifestations and metabolic control, including single and composite outcomes and substantial heterogeneity preventing statistical combination. No evidence was found of differences in neurological deterioration (main outcome), but differences were found among interventions in some comparisons to normalize acid-base status (∼2 h less with low vs. high volume); time to receive subcutaneous insulin (∼1 h less with low vs. high fluid rate); length of stay (∼6 h less with RL vs. saline); and resolution of the DKA (∼3 h less with two-bag vs. one-bag scheme). However, available evidence is scarce and poor.

Conclusions: There is not enough evidence to determine the best fluid therapy in terms of fluid type, tonicity, volume, or administration time for DKA treatment. There is an urgent need for more RCTs, and the development of a core outcome set on DKA in children.

Keywords

core outcomes set / crystalloid solutions / diabetic ketoacidosis / fluid therapy / infusions / intravenous / neurologic manifestations

References

[1] International Diabetes Federation. Idf Diabetes Atlas. 10th ed.

[2] Jacobsen LM, Haller MJ, Schatz DA. Understanding pre-type 1 diabetes: the key to prevention. Front Endocrinol (Lausanne). 2018; 9: 70.

[3] Usher-Smith JA, Thompson MJ, Sharp SJ, Walter FM. Factors associated with the presence of diabetic ketoacidosis at diagnosis of diabetes in children and young adults: a systematic review. BMJ. 2011; 343:d4092.

[4] Wolfsdorf JI, Glaser N, Agus M, et al. ISPAD Clinical Practice Consensus Guidelines 2018: diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Pediatr Diabetes. 2018; 19: 155–177. Suppl.

[5] Varadarajan P, Suresh S. Delayed diagnosis of diabetic ketoacidosis in children—a cause for concern. Int J Diabetes Dev Ctries. 2015; 35(2), 66–70.

[6] Decourcey DD, Steil GM, Wypij D, Agus MSD. Increasing use of hypertonic saline over mannitol in the treatment of symptomatic cerebral edema in pediatric diabetic ketoacidosis: an 11-year retrospective analysis of mortality. Pediatric Critical Care Medicine. 2013; 14(7), 694–700.

[7] Heddy N. Guideline for the management of children and young people under the age of 18 years with diabetic ketoacidosis (British Society for Paediatric Endocrinology and Diabetes). Arch Dis Child Educ Pract Ed. 2021; 106(4), 220–222.

[8] Prentice P. Updated NICE guidance: diabetic ketoacidosis in children and young people 2020. Arch Dis Child Educ Pract Ed. 2021; 106(4), 229.

[9] Florez ID, Sierra J, Pérez-Gaxiola G. Balanced crystalloid solutions versus 0.9% saline for treating acute diarrhoea and severe dehydration in children. Cochrane Database Syst Rev. 2023; 5(5), CD013640.

[10] Bampoe S, Odor PM, Dushianthan A, et al. Perioperative administration of buffered versus non-buffered crystalloid intravenous fluid to improve outcomes following adult surgical procedures. Cochrane Database Syst Rev. 2017; 9(9), CD004089.

[11] Antequera Martín AM, Barea Mendoza JA, Muriel A, et al. Buffered solutions versus 0.9% saline for resuscitation in critically ill adults and children. Cochrane Database Syst Rev. 2019; 7(7), CD012247.

[12] Ronsley R, Islam N, Ronsley C, Metzger DL, Panagiotopoulos C. Adherence to a pediatric diabetic ketoacidosis protocol in children presenting to a tertiary care hospital. Pediatr Diabetes. 2018; 19(2), 333–338.

[13] Zucchini S, Scaramuzza AE, Bonfanti R, et al, Diabetes Study Group of The Italian Society For Pediatric Endocrinology And Diabetology. A multicenter retrospective survey regarding diabetic ketoacidosis management in italian children with type 1 diabetes. J Diabetes Res. 2016; 2016:5719470.

[14] Kuppermann N, Ghetti S, Schunk JE, et al. Clinical trial of fluid infusion rates for pediatric diabetic ketoacidosis. N Engl J Med. 2018; 378(24), 2275–2287.

[15] Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; 372: n71.

[16] Campbell M, McKenzie JE, Sowden A, et al. Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. BMJ. 2020; 368:l6890.

[17] Higgins JPT, Green S, Altman DG, Sterne JAC, eds. Chapter 8: assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (Updated June 2017). Wiley-Blackwell; 2017: 649. Accessed February 12, 2022. editors.

[18] Poirier Michael P, GDSSM. A prospective study of the “two-bag system” in diabetic ketoacidosis management. Clin Pediatr (Phila). 2004; 43(9), 800–813.

[19] Glaser NS, Wootton-Gorges SL, Buonocore MH, et al. Subclinical cerebral edema in children with diabetic ketoacidosis randomized to 2 different rehydration protocols. Pediatrics. 2013; 131(1), e73–e80.

[20] Pablo Ferreira J, Penazzi M, Macarena Taboada D, Funes S, Villarreal M. A comparison of two systems for hydration of children with diabetic ketoacidosis. a randomized controlled trial. Revista de la Facultad de ciencias Médicas. 2015; 72(2), 93–99.

[21] Bakes K, Haukoos JS, Deakyne SJ, et al. Effect of volume of fluid resuscitation on metabolic normalization in children presenting in diabetic ketoacidosis: a randomized controlled trial. J Emerg Med. 2016; 50(4), 551–559.

[22] Yung M, Letton G, Keeley S. Controlled trial of Hartmann's solution versus 0.9% saline for diabetic ketoacidosis. J Paediatr Child Health. 2017; 53(1), 12–17.

[23] Dhochak N, Jayashree M, Singhi S. A randomized controlled trial of one bag vs. two bag system of fluid delivery in children with diabetic ketoacidosis: experience from a developing country. J Crit Care. 2018; 43: 340–345.

[24] Shafi O, Kumar V. Initial fluid therapy in pediatric diabetic ketoacidosis: a comparison of hypertonic saline solution and normal saline solution. Pediatr Endocrinol Diabetes Metab. 2018; 24(2), 56–64.

[25] Williams V, Jayashree M, Nallasamy K, Dayal D, Rawat A. 0.9% saline versus Plasma-Lyte as initial fluid in children with diabetic ketoacidosis (SPinK trial): a double-blind randomized controlled trial. Crit Care. 2020; 24(1), 1.

[26] Glaser NS, Stoner MJ, Garro A, et al. Serum sodium concentration and mental status in children with diabetic ketoacidosis. Pediatrics. 2021; 148(3), e2021050243.

[27] Rewers A, Kuppermann N, Stoner MJ, et al. Effects of fluid rehydration strategy on correction of acidosis and electrolyte abnormalities in children with diabetic ketoacidosis. Diabetes Care. 2021; 44(9), 2061–2068.

[28] Shourya Vijay Tej Kola VKSGVC. IAP ResRCHcon 2020 Abstracts. Indian J Pediatr. 2020; 87(11), 974–988.

[29] Lehr AR, Rached-D'Astous S, Barrowman N, et al. Balanced versus unbalanced fluid in critically ill children: systematic review and meta-analysis. Pediatric Critical Care Medicine. 2022; 23(3), 181–191.

[30] Holliday MA, Ray PE, Friedman AL. Fluid therapy for children: facts, fashions and questions. Arch Dis Child. 2007; 92(6), 546–550.

[31] Santi M, Lava SAG, Camozzi P, et al. The great fluid debate: saline or so-called “balanced” salt solutions? Ital J Pediatr. 2015; 41(1), 47.

[32] Jayashree M, Williams V, Iyer R. Fluid therapy for pediatric patients with diabetic ketoacidosis: current perspectives. Diabetes Metab Syndr Obes. 2019; 12: 2355–2361.

[33] Campos Miño S, Moreno Castro M. Fluidoterapia y electrolitos parenterales en pediatría. Metro Ciencia. 2020; 28(4), 4–15.

[34] Brown TB. Cerebral oedema in childhood diabetic ketoacidosis: is treatment a factor? Emerg Med J. 2004; 21(2), 141–144.

[35] Azova S, Rapaport R, Wolfsdorf J. Brain injury in children with diabetic ketoacidosis: review of the literature and a proposed pathophysiologic pathway for the development of cerebral edema. Pediatr Diabetes. 2021; 22(2), 148–160.

[36] Agarwal N, Dave C, Patel R, Shukla R, Kapoor R, Bajpai A. Factors associated with cerebral edema at admission in Indian children with diabetic ketoacidosis. Indian Pediatr. 2020; 57(4), 310–313.

[37] Hsia DS, Tarai SG, Alimi A, Coss-Bu JA, Haymond MW. Fluid management in pediatric patients with DKA and rates of suspected clinical cerebral edema. Pediatr Diabetes. 2015; 16(5), 338–344.

[38] So TY, Grunewalder E. Evaluation of the two-bag system for fluid management in pediatric patients with diabetic ketoacidosis. JPPT. 2009; 14(2), 100.

[39] Hasan RA, Hamid K, Dubre D, Nolan B, Sharman M. The two-bag system for intravenous fluid management of children with diabetic ketoacidosis: experience from a community-based hospital. Glob Pediatr Health. 2021; 8:2333794X21991532.

[40] Hamud AA, Mudawi K, Shamekh A, Kadri A, Powell C, Abdelgadir I. Diabetic ketoacidosis fluid management in children: systematic review and meta-analyses. Arch Dis Child. 2022; 107(11), 1023–1028.

[41] Clarke M, Williamson PR. Core outcome sets and systematic reviews. Syst Rev. 2016; 5(1), 11.

[42] Williamson PR, Altman DG, Blazeby JM, et al. Developing core outcome sets for clinical trials: issues to consider. Trials. 2012; 13: 132.

[43] Lei R, Shen Q, Yang B, et al. Core outcome sets in child health. JAMA Pediatr; 176(11), 1131–1141.

[44] Webbe J, Sinha I, Gale C. Core outcome sets. Arch Dis Child Educ Pract Ed. 2018; 103(3), 163–166.

[45] Gorst SL, Gargon E, Clarke M, Blazeby JM, Altman DG, Williamson PR. Choosing important health outcomes for comparative effectiveness research: an updated review and user survey. PLoS One. 2016; 11(1), e0146444.

[46] COMET Initiative | Home. Accessed February 13, 2022.

[47] al Khalifah R, Florez ID, Guyatt G, Thabane L. Network meta-analysis: users’ guide for pediatricians. BMC Pediatr. 2018; 18(1), 180.

RIGHTS & PERMISSIONS

2024 The Authors. Journal of Evidence-Based Medicine published by Chinese Cochrane Center, West China Hospital of Sichuan University and John Wiley & Sons Australia, Ltd.